Products containing dangerous chemicals could get EU green label
As the EU pursues its war on red tape, proposed changes to sustainability rules could see harmful chemicals permitted on the ...
pharmaphorum5d
AZ’s Forxiga gets heart claim data on its EU label
AstraZeneca has been cleared to include cardiovascular and kidney outcomes data on the label of its type 2 diabetes therapy Forxiga in the EU which could help it challenge rival drugs in the SGLT2 ...
pharmaphorum4d
EU gives narrower label to Apellis, Sobi's PNH drug
Apellis Pharma and partner Sobi have won EU approval for their paroxysmal nocturnal haemoglobinuria (PNH) drug pegcetacoplan in Europe, with a more restricted label than in the US. The European ...